Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Merck & Company (MRK – Research Report). The ...

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target ...

Robert F. Kennedy Jr., who awaits confirmation as Donald Trump's Health and Human Services secretary, helped organize mass ...

We recently compiled a list of the 12 Most Reliable Dividend Stocks To Buy According to Hedge Funds. In this article, we are ...

Herrmann will continue in her role as chief of staff to EVP and chief communications and public affairs officer Cristal Downing.

Today's Research Daily features a real-time update on the Q4 earnings season and fresh Chevron (CVX), Merck (MRK), QUALCOMM ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

According to Davis, "the breadth and the depth" of Merck's current pipeline is the most diversified in the company's recent history, with its portfolio is broadening into the cardiometabolic space ...

With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc ... and Animal Health segments. The company is known for its innovative products, including Keytruda, Gardasil ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... of retired baby boomers seeking income. With cash products yielding around 4%, there is a strong demand for ...